These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2282131)

  • 21. Methylphenidate for alpha-interferon induced depression.
    Camacho A; Ng B
    J Psychopharmacol; 2006 Sep; 20(5):687-9. PubMed ID: 16533869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Should psychostimulants be used to treat delirious patients with depressed mood?
    Levenson JA
    J Clin Psychiatry; 1992 Feb; 53(2):69. PubMed ID: 1541609
    [No Abstract]   [Full Text] [Related]  

  • 23. d-Amphetamine versus methylphenidate effects in depressed inpatients.
    Little KY
    J Clin Psychiatry; 1993 Sep; 54(9):349-55. PubMed ID: 8407854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elderly depressed females as a possible subgroup of patients responsive to methylphenidate.
    Askinazi C; Weintraub RJ; Karamouz N
    J Clin Psychiatry; 1986 Sep; 47(9):467-9. PubMed ID: 3745129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychostimulant treatment of depressive disorders secondary to medical illness.
    Woods SW; Tesar GE; Murray GB; Cassem NH
    J Clin Psychiatry; 1986 Jan; 47(1):12-5. PubMed ID: 3941052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The plasma level of methylphenidate in the single-dose oral methylphenidate test.
    Van Kempen GM; Goekoop JG; Jong HB; Edelbroek PM; de Wolff FA
    Biol Psychiatry; 1990 Oct; 28(7):638-40. PubMed ID: 2223930
    [No Abstract]   [Full Text] [Related]  

  • 27. Depression in the medically ill elderly: a focus on methylphenidate.
    Emptage RE; Semla TP
    Ann Pharmacother; 1996 Feb; 30(2):151-7. PubMed ID: 8835049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychostimulants for depression in the medically ill.
    Frierson RL; Wey JJ; Tabler JB
    Am Fam Physician; 1991 Jan; 43(1):163-70. PubMed ID: 1986485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylphenidate-induced obsessive-compulsive symptoms in an elderly man.
    Serby M
    CNS Spectr; 2003 Aug; 8(8):612-3. PubMed ID: 12907924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of once-daily oral and transdermal methylphenidate on sleep behavior of children with ADHD.
    Faraone SV; Glatt SJ; Bukstein OG; Lopez FA; Arnold LE; Findling RL
    J Atten Disord; 2009 Jan; 12(4):308-15. PubMed ID: 18400982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase II study of methylphenidate for depression in advanced cancer.
    Homsi J; Nelson KA; Sarhill N; Rybicki L; LeGrand SB; Davis MP; Walsh D
    Am J Hosp Palliat Care; 2001; 18(6):403-7. PubMed ID: 11712722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychostimulants in post-stroke depression.
    Masand P; Murray GB; Pickett P
    J Neuropsychiatry Clin Neurosci; 1991; 3(1):23-7. PubMed ID: 7580168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder.
    Spencer T; Wilens T; Biederman J; Faraone SV; Ablon JS; Lapey K
    Arch Gen Psychiatry; 1995 Jun; 52(6):434-43. PubMed ID: 7771913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sustained-release methylphenidate in methamphetamine dependence treatment: a double-blind and placebo-controlled trial.
    Rezaei F; Emami M; Zahed S; Morabbi MJ; Farahzadi M; Akhondzadeh S
    Daru; 2015 Jan; 23(1):2. PubMed ID: 25588930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do the old psychostimulant drugs have a role in managing treatment-resistant depression?
    Parker G; Brotchie H
    Acta Psychiatr Scand; 2010 Apr; 121(4):308-14. PubMed ID: 19594481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychostimulant treatment of geriatric depressive disorders secondary to medical illness.
    Pickett P; Masand P; Murray GB
    J Geriatr Psychiatry Neurol; 1990; 3(3):146-51. PubMed ID: 2282130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Desipramine and methylphenidate combination treatment for depression: case report.
    Drimmer EJ; Gitlin MJ; Gwirtsman HE
    Am J Psychiatry; 1983 Feb; 140(2):241-2. PubMed ID: 6849446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coadministration of phenelzine and methylphenidate for treatment-resistant depression.
    Shelton Clauson A; Elliott ES; Watson BD; Treacy J
    Ann Pharmacother; 2004 Mar; 38(3):508. PubMed ID: 14970373
    [No Abstract]   [Full Text] [Related]  

  • 39. Multicentre, double-blind, randomised placebo-controlled clinical trial on the efficacy of methylphenidate on depressive symptoms in advanced cancer patients.
    Centeno C; Sanz A; Cuervo MA; Ramos D; Hernansanz S; Gonzalez J; Almaraz MJ; Lama M; Vara F; Nabal M; Pascual A
    BMJ Support Palliat Care; 2012 Dec; 2(4):328-33. PubMed ID: 24654216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multicenter, open-label trial to evaluate the quality of life in adults with ADHD treated with long-acting methylphenidate (OROS MPH): Concerta Quality of Life (CONQoL) study.
    Mattos P; Louzã MR; Palmini AL; de Oliveira IR; Rocha FL
    J Atten Disord; 2013 Jul; 17(5):444-8. PubMed ID: 22334621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.